Premium
Novel specific human and mouse stromelysin‐1 (MMP‐3) and stromelysin‐2 (MMP‐10) antibodies for biochemical and immunohistochemical analyses
Author(s) -
Mirastschijski Ursula,
Dinesh Nilima,
Baskaran Sudarson,
Wedekind Dirk,
Gavrilovic Jelena,
Murray Megan Y.,
Bevan Damon,
Kelm Sørge
Publication year - 2019
Publication title -
wound repair and regeneration
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.847
H-Index - 109
eISSN - 1524-475X
pISSN - 1067-1927
DOI - 10.1111/wrr.12704
Subject(s) - matrix metalloproteinase , antibody , collagenase , gelatinases , immunohistochemistry , extracellular matrix , biology , chemistry , microbiology and biotechnology , enzyme , biochemistry , immunology , gelatinase
Abstract Matrix metalloproteinases (MMP) are a family of more than 25 zinc‐dependent enzymes that are centrally involved in cellular migration, tissue remodeling, cancer invasion and metastasis. Besides degrading extracellular matrix proteins, MMPs are crucial for growth factor and cytokine release and activation. At the same time, they can inactivate inflammatory mediators and enzymes themselves through protein degradation. Subclasses of MMPs include collagenases, gelatinases, stromelysins, membrane‐bound MMPs, and others. With regard to the stromelysin subfamily, three members exist, e.g., stromelysin‐1 (MMP‐3), stromelysin‐2 (MMP‐10), and stromelysin‐3 (MMP‐11). MMP‐3, and MMP‐10 share extensive similarities at the amino acid level that made it difficult to develop specific antibodies distinguishing between MMP‐3 and MMP‐10. Scrutinizing published data on and performing different analyses with detection of both stromelysins with commercially available or lab‐made antibodies showed ambiguous results with regard to specificity of antibodies used to date. We developed new specific antibodies against the most divergent parts of the active forms of both proteins. We assessed the specificity of our novel specific anti‐human and anti‐mouse MMP‐3 and MMP‐10 antibodies in cell lysates and different human and murine skin tissues. Tests analyzing specificity of the novel antibodies included Western immunoblotting, immunofluorescence, and immunohistochemistry on paraffin sections. Analyses demonstrated specific detection of respective protein for human or mouse samples except for the anti‐human MMP‐3 antibody. The aim of this summary was to call attention the MMP research community to distinguish clearly between both enzymes. Our new specific anti‐mouse MMP‐3 and both MMP‐10 antibodies allow us to address this detection problem and to enable comparative studies between both stromelysins with regard to their respective location and function in the tissue.